FDA.reportPublic FDA data

Byfavo 20 MG (equivalent to remimazolam besylate 27.2 MG) Injection

RxCUI
2383951
RxNorm name
Byfavo 20 MG (equivalent to remimazolam besylate 27.2 MG) Injection
Display name
Byfavo 20 MG (equivalent to remimazolam besylate 27.2 MG) Injection
Full name
Byfavo 20 MG (equivalent to remimazolam besylate 27.2 MG) Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4e1838f2-b999-41a7-a761-d94f09aa531fByfavo 20 MG (equivalent to remimazolam besylate 27.2 MG) InjectionSY9These highlights do not include all the information needed to use BYFAVO safely and effectively. See full prescribing information for BYFAVO. BYFAVO ® (remimazolam) for injection, for intravenous use, CIV Initial U.S. Approval: 202020250220
4e1838f2-b999-41a7-a761-d94f09aa531fByfavo 20 MG InjectionPSN9These highlights do not include all the information needed to use BYFAVO safely and effectively. See full prescribing information for BYFAVO. BYFAVO ® (remimazolam) for injection, for intravenous use, CIV Initial U.S. Approval: 202020250220
4e1838f2-b999-41a7-a761-d94f09aa531fremimazolam 20 MG Injection [Byfavo]SBD9These highlights do not include all the information needed to use BYFAVO safely and effectively. See full prescribing information for BYFAVO. BYFAVO ® (remimazolam) for injection, for intravenous use, CIV Initial U.S. Approval: 202020250220